Andrzej Jakubowiak

Trials

Studies that name Andrzej Jakubowiak as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:03 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT03729804 · Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)

  University of Chicago · active not recruiting · Multiple Myeloma · principal investigator
• Ph2
  NCT02969837 · Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma

  University of Chicago · completed · Multiple Myeloma · principal investigator
• Ph3
  NCT02659293 · Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma

  University of Chicago · active not recruiting · Multiple Myeloma · principal investigator
• Ph2
  NCT02389517 · Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant

  University of Chicago · completed · Plasma Cell Myeloma, Residual Disease · principal investigator
• Ph1
  NCT02199665 · Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

  University of Chicago · completed · Refractory Multiple Myeloma · principal investigator
• Ph2
  NCT01816971 · Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

  University of Chicago · completed · Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma · principal investigator
• Ph1/Ph2
  NCT01665794 · Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

  University of Chicago · completed · Multiple Myeloma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 13:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Clinical and Experimental Therapeutics
  P30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI Wendy Stock · fiscal years 2010 to 2026
  Named on NCT02389517, NCT02199665